Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other solid neoplasm 2Genitourinary 2Gastrointestinal 2CNS 2Gynecologic 1

Conditions

Myelodysplastic Syndromes 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Leukemia, Myeloid, Acute 6Medulloblastoma 5Lymphoma 5Sarcoma 4Hematologic Neoplasms 4Central Nervous System Neoplasms 4Brain Neoplasms 4Astrocytoma 4Rhabdoid Tumor 3Ovarian Neoplasms 3Glioma 3Ependymoma 3Burkitt Lymphoma 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Rhabdomyosarcoma 2Retinoblastoma 2Primary Myelofibrosis 2Pinealoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Myeloproliferative Disorders 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Liver Neoplasms 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Melphalan 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Etoposide 4Carboplatin 4Cyclophosphamide 3Busulfan 3Topotecan 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Ifosfamide 2sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1alvocidib 1Vincristine 1Thrombopoietin 1Thalidomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Mesna 1Maxitrol 1Cryotherapy 1Brachytherapy 1Bone Marrow Transplantation 1Biological Factors 1Anti-Infective Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Retinoblastoma × Thiotepa × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡